Folliculitis Decalvans

Folliculitis Decalvans is a rare, chronic inflammatory condition of the scalp characterized by painful, itchy pustules and crusts, often resulting in permanent hair loss and scarring. Patients typically notice persistent red bumps, pus-filled lesions, and crusts, often accompanied by itching, burning, or pain, primarily on the top and back of the scalp. A hallmark sign is the appearance of "tufted hairs," where several hair shafts emerge from a single follicular opening, resembling a doll's hair. Over time, these inflamed areas destroy the hair follicles, replacing them with scar tissue, which is smooth, shiny, and devoid of hair, leading to progressive and irreversible balding patches.

The underlying mechanism of Folliculitis Decalvans is not fully understood, but it's believed to be an aberrant immune response to common bacteria, particularly *Staphylococcus aureus*, residing on the scalp. This immune reaction leads to chronic inflammation around the hair follicles, eventually destroying them. Diagnosis is primarily clinical, based on the characteristic appearance of pustules, crusts, scarring, and tufted hairs. A scalp biopsy is often performed to confirm the diagnosis, revealing lymphocytic and neutrophilic inflammation around the hair follicles, followed by their destruction and replacement with fibrous scar tissue. Hair pull tests in affected areas would be negative, confirming the stability of existing hair but also the permanent loss in scarred regions.

This condition significantly impacts a patient's hair transplant outcome because hair cannot grow from scarred tissue. Any attempt to transplant grafts into areas affected by Folliculitis Decalvans is doomed to fail; the transplanted follicles simply won't survive or thrive in the fibrotic, avascular environment. Moreover, if the disease is not adequately controlled and remains active, it can spread to previously healthy areas, potentially jeopardizing transplanted hair in adjacent regions or even new hair if the disease reactivates. Therefore, achieving full disease remission is paramount before considering any hair restoration procedure.

Successfully managing Folliculitis Decalvans is a long-term commitment, often involving a combination of oral antibiotics, typically rifampicin and clindamycin, to suppress bacterial populations and topical or injectable corticosteroids to reduce inflammation. In some cases, other immune-modulating drugs may be used. Patients should expect to be on medication for several months, often six months to a year or more, to achieve and maintain remission. Even with successful treatment, the hair lost in scarred areas will not regrow. A common mistake is to attempt hair transplantation too soon, before the condition has been stable and inactive for at least one to two years, as recurrence can compromise the transplant.

When considering hair transplantation in Turkey, it is crucial to ensure that your Folliculitis Decalvans is fully inactive and has been stable for a prolonged period, typically 12-24 months, with no new lesions or active inflammation. You should ask potential clinics specifically about their experience with patients who have a history of scarring alopecia, like Folliculitis Decalvans. Inquire about their protocol for assessing disease activity, which should include a thorough clinical examination, potentially a biopsy review, and a clear understanding of your treatment history. Be wary of any clinic that promises success without a rigorous evaluation of your condition's stability. A reputable clinic will prioritize disease control and patient safety above all else, often recommending against transplantation if there's any doubt about the disease's inactivity, or limiting transplants to completely unaffected regions while closely monitoring the scalp.